Major television station and news channel FTV (Formosa TV) based in Taipei, Taiwan covered MEDIPOST’s technologies and achievements in stem cell research.

FTV’s main new program, FTV News covered MEDIPOST’s principles and techniques behind administering MEDIPOST’s stem cell drug ‘CARTISTEM^®’ for treating degenerative arthritis, MEDIPOST’s patents in stem cell technologies and research facility in depth over two episodes.

FTV News introduced MEDIPOST as a “Korean company specializing in stem cell therapy, holding three ‘secret weapons’ including the recently launched Alzheimer’s disease drug ‘NEUROSTEM^®’ and a drug for treating lung conditions of premature babies.

” FTV News also added, “MEDIPOST is a promising company that is highly likely to enter the global market in near future.”